About Index Trending news
Lists
Pricing
Reata Pharmaceuticals

Reata Pharmaceuticals

Reata Pharmaceuticals

Reata Pharmaceuticals, Inc. translates innovative science into breakthrough medicines for a broad range of intractable diseases.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding Show all
Post-IPO debt
$35,000,000
IPO
$60,500,000
Employees

Team size

10+
Locations
HQ
Headquarters
$35,000,000 Post-IPO debt
biospace

Reata Pharmaceuticals Inc Secures 35 Million Term Loan Facility